Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cyclophosphamide-induced pneumonitis].

E Glatt1, M Henke, G Sigmund

  • 1Radiologische Universitätsklinik, Freiburg i. Br., Abt. Röntgendiagnostik.

Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|May 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical characteristics of wildfire ash across the globe and their environmental and socio-economic implications.

Environment international·2023
Same author

Comparison of a 22G Crown-Cut Needle with a Conventional 22G Needle with EBUS Guidance in Diagnosis of Sarcoidosis.

Lung·2022
Same author

Biopsy-derived oral keratinocytes - A model to potentially test for oral mucosa radiation sensitivity.

Clinical and translational radiation oncology·2022
Same author

[Linguistic Validation of the "German Lung Fibrosis Health Related Quality of Life Questionnaire"].

Pneumologie (Stuttgart, Germany)·2021
Same author

[German Guideline for Idiopathic Pulmonary Fibrosis].

Pneumologie (Stuttgart, Germany)·2020
Same author

Pneumologie (Stuttgart, Germany)·2020

Cyclophosphamide chemotherapy can cause rare lung damage. A case study shows these pulmonary changes can appear subacutely and reverse with corticosteroid treatment.

Area of Science:

  • Oncology
  • Pulmonology
  • Pharmacology

Background:

  • Cyclophosphamide is a widely used chemotherapy agent.
  • Drug-induced pneumotoxicity is a known but rare complication.
  • Pulmonary complications of cyclophosphamide have been documented in limited case reports.

Observation:

  • A patient developed subacute lung changes after a single dose of cyclophosphamide.
  • The observed lung toxicity presented with specific radiological and clinical features.
  • This case adds to the existing literature on cyclophosphamide-induced lung injury.

Findings:

  • The patient's pneumotoxicity manifested in a subacute manner.
  • Treatment with corticosteroids led to a reversal of the lung changes.
  • This suggests a potential therapeutic strategy for cyclophosphamide-induced lung injury.

Related Experiment Videos

Implications:

  • Highlights the importance of monitoring for pulmonary toxicity during cyclophosphamide therapy.
  • Suggests corticosteroids as a potential treatment for cyclophosphamide-induced pneumotoxicity.
  • Contributes to understanding the spectrum and management of adverse drug reactions in chemotherapy.